Robust cost efficacy of a novel, validated screening test at 12–20 ​Weeks gestation for the prediction of preterm birth (PTB) at or before 32 ​Weeks in singletons

Journal article

Open access

Robust cost efficacy of a novel, validated screening test at 12–20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons

R. H. Lee and C. P. Weiner

Gynecology and Obstetrics Clinical Medicine, Vol.1(3)

2021

url

https://doi.org/10.1016/j.gocm.2021.07.001View

Published (Version of record) Open

1 Record Views

Title: Robust cost efficacy of a novel, validated screening test at 12–20 Weeks gestation for the prediction of preterm birth (PTB) at or before 32 Weeks in singletons
Creators: R. H. Lee - University of Kansas
C. P. Weiner - University of Kansas
Publication Details: Gynecology and Obstetrics Clinical Medicine, Vol.1(3)
Identifiers: 991006040109402656
Academic Unit: Obstetrics & Gynecology
Resource Type: Journal article